Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Canada’s top edible cannabis producer eyes further growth

The following is a transcription of the above video, and The Market Online has edited it for clarity . Edible cannabis producer, Indiva Ltd. (TSXV:NDVA) , recently announced a LIFE private placement, open to all retail investors, and intends to raise a minimum of $...

Biopharma Reports Consistent 'Phase 2 Liver Fat (NASH and NAFLD) Results'

The new data are reviewed and updates are provided on Can-Fite BioPharma's other clinical studies, including one for COVID-19, in this Dawson James research report. In an April 20 research note, Dawson James analyst Jason Kolbert wrote that results from Can...

ION Energy: Mongolia's first lithium brine explorer & developer

ION Energy is in the business of exploration and development of lithium brine in Mongolia. ION is currently focused on two projects, their flagship project just 24 km from the Chinese border and another bringing their company to a total of over 110 thousand hectares ...

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...

Biopharma Shows 'Good Start to 2020 News Flow'

The two developments that already took place this year are addressed in an H.C. Wainwright & Co. report. In a Jan. 16 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Ligand Pharmaceuticals Inc. (LGND:NASDAQ) kicked off the year with news ...

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...

Could DehydraTECH CBD be Worth $3 Billion a Year to Lexaria?

PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 milli on people per year . L...

Aftermath Locks up a Boatload of Silver

When the precious metals bull begins to roar, silver roars along with it. In general, when the metals go down silver goes down more and faster than gold. When precious metals climb, silver climbs faster and goes higher. So if you believe that we are in a metals bull mar...

Nevada Copper Delivers Copper Now

A very short nine weeks ago I was giving good advice to my readers when I said: "I was writing about Nevada Copper Corp. (NCU:TSX; NEVDF:OTC) five months ago and the shares were $0.395. Today as the price of copper has gone down by ten percent and we move into tax...
1 2 3